CClinicalTrials.gg
CompletedNCT07103096IcareUpdated Aug 10, 2026

Infiltration in Rheumatology With 3D Virtual Reality Headset Pilot Study for the Evaluation of Satisfaction (ICARE)

An observational study in Infiltration, sponsored by Assistance Publique - Hôpitaux de Paris. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-10.

Sponsored by Assistance Publique - Hôpitaux de Paris · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
30
Ages
18 Years and older
Sex
All
01

Study summary

This study is to evaluate the satisfaction and feasibility according to the location of the use of a 3D virtual reality headset during an infiltration in rheumatology.

Read the detailed description

The performance of infiltrative procedures in rheumatology is common, even daily, practice. It may be associated with anticipatory anxiety and pain (for example, during a shoulder infiltration, there is a significant difference between anticipated pain and pain felt with a visual analogue scale of 6.03 versus 3.17, P \< 0.001) as well as pain and anxiety during the procedure. Certain techniques are used to limit this anxiety and pain in common practice such as explaining the procedure before and during its performance, the atmosphere (particularly musical atmosphere) and decoration of the room where the procedure takes place (relaxing images visible to the patient, brightness, people present) and the attitude of the practitioner. More recently, hypnosis and/or 3D virtual reality techniques using a virtual reality headset have been implemented in medicine and particularly in rheumatology to help manage chronic or acute pain. Thus, we currently use a virtual reality headset associated with hypnotic induction (using an audio headset) for the performance of many infiltrative procedures. However, there is no data concerning the acceptability and satisfaction of the patient and the physician of the addition of this technique (VR headset with hypnotic induction) nor its feasibility in current practice (extension of the procedure time for example), during an infiltration nor to know if these data can vary according to the infiltrated location.

02

Conditions studied

  • Infiltration

Keywords

  • infiltration
  • 3D virtual reality headset
03

In context

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,505 studies on the registry; 1,006 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patient requiring infiltration of the spine (high epidural or sacrococcygeal hiatus) of the subacromial-deltoid bursa or the knee

Inclusion criteria

  • 18 years or older
  • Patient requiring infiltration of the spine (high epidural or sacrococcygeal hiatus) of the subacromial-deltoid bursa or the knee, regardless of the product infiltrated
  • Within the Rheumatology department of Saint-Antoine hospital (consultation or hospitalized)

Exclusion criteria

Exclusion Criteria:

  • History of severe psychiatric disorders - History of epilepsy
  • Cognitive disorders
  • Language barrier - Hearing aid-assisted deafness and/or ophthalmological problems leading to a major loss of vision (advanced cataract, visual impairment)
  • Infiltration of the spine (high epidural or sacrococcygeal hiatus), subacromial-deltoid bursa or knee \< 6 months
  • Characterized depressive disorder diagnosed recently (for less than 6 months) or not stabilized
  • Previous use of a virtual reality headset during treatment
  • Being under guardianship or curatorship
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
30 participants (actual)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Infiltration

    Patient requiring infiltration of the spine (high epidural or sacrococcygeal hiatus) of the subacromial-deltoid bursa or the knee

06

What researchers measure

Primary outcomes

  1. To assess patient satisfaction with the use of 3D virtual reality with hypnotic induction during infiltration using Modified Client satisfaction score (CSQ-8)

    Modified Client satisfaction score (CSQ-8) Minimum value: 0= not satisfied. Maximum value= 4 totally satisfied. Higher score mean better outcome.

    Time frame: day one

Secondary outcomes

  1. To assess investigator satisfaction

    Number of times the doctor is satisfied according to the 5-point Likert scale of satisfaction. Minimum value: 0= not satisfied. Maximum value= 5 totally satisfied. Higher score mean better outcome.

    Time frame: Day one

  2. To Modified Client satisfaction score (CSQ-8) score according to the location of the infiltration

    Modified Client satisfaction score (CSQ-8) according to the location of the infiltration. Minimum value: 0= not satisfied. Maximum value= 4 totally satisfied. Higher score mean better outcome.

    Time frame: Day one

  3. Assess the patient's anxiety during infiltration using a numerical scale

    Numerical scale patient anxiety during infiltration: mean (standard deviation). Minimum value: 0= Not at all anxious. Maximum value= 10 very anxious. Higher score mean worse outcome.

    Time frame: day one

  4. To Assess the patient's pain during the infiltration using a numerical scale.

    Patient pain numerical scale during infiltration: mean (standard deviation) Minimum value: 0= no pain. Maximum value= 10 the worst pain imaginable. Higher score mean worse outcome.

    Time frame: day one

  5. To Compare pain during infiltration to anticipated pain from infiltration using a numerical scale

    * Numerical scale of pain during infiltration Minimum value: 0= no pain. Maximum value= 10 the worst pain imaginable. Higher score mean worse outcome. * Numerical scale of anticipated pain of infiltration. Minimum value: 0= no anticipated pain. Maximum value= 10 the worst anticipated pain imaginable. Higher score mean worse outcome.

    Time frame: day one

  6. Evaluate the added duration of the gesture by using the virtual reality headset

    Duration of the gesture in minutes

    Time frame: day one

  7. Compare the duration of the gesture with hypnotic 3D virtual reality versus the assumed duration without the use of the headset

    Average added time by the Virtual Reality headset according to the doctor

    Time frame: day one

  8. Describe the tolerance of the Virtual Reality headset

    Proportion of immediate side effects to the virtual reality headset

    Time frame: day one

07

Study locations

1 site
  • Rheumatology department Hôpital Saint Antoine
    Paris, 75012, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07103096
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Responsible party
Sponsor
First posted
Aug 5, 2025
Start date
May 28, 2025
Primary completion
May 28, 2026
Completion
May 28, 2026
Last update
Aug 10, 2026

Study contacts

Alice COURTIES, Medical doctor
principal investigator · APHP

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion